Cargando…

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma

Immunohistochemistry plays an indispensable role in accurate diagnosis of malignant mesothelioma, particularly in morphologically challenging cases and in biopsy and cytology specimens, where tumor architecture is difficult or impossible to evaluate. Application of a targeted panel of mesothelial- a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chapel, David B., Schulte, Jefree J., Husain, Aliya N., Krausz, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082260/ https://www.ncbi.nlm.nih.gov/pubmed/32206567 http://dx.doi.org/10.21037/tlcr.2019.11.29

Ejemplares similares

Update on the pathologic diagnosis of malignant mesothelioma
por: Schulte, Jefree J., et al.
Publicado: (2020)

Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
por: White, Michael G., et al.
Publicado: (2020)

Clinical and Molecular Validation of BAP1, MTAP, P53, and Merlin Immunohistochemistry in Diagnosis of Pleural Mesothelioma
por: Chapel, David B., et al.
Publicado: (2022)

Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
por: Sandeck, Helmut P, et al.
Publicado: (2010)

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
por: Pulford, Emily, et al.
Publicado: (2017)

Pain management in patients with malignant mesothelioma: challenges and solutions
por: Saunders, J, et al.
Publicado: (2019)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion
por: Halimi, Monireh, et al.
Publicado: (2019)

Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016)

The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
por: Rozitis, Eric, et al.
Publicado: (2020)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant Peritoneal Mesothelioma: An In-Depth and Up-to-Date Review of Pathogenesis, Diagnosis, Management and Future Directions
por: Karpes, Josh B., et al.
Publicado: (2023)

Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors
por: Takahashi, Yoshihisa, et al.
Publicado: (2021)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
por: Musso, Valeria, et al.
Publicado: (2021)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Evaluation of clonal origin of malignant mesothelioma
por: Comertpay, Sabahattin, et al.
Publicado: (2014)

Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomas
por: Hiroshima, Kenzo, et al.
Publicado: (2021)

Mesothelium and Malignant Mesothelioma
por: Hiriart, Emilye, et al.
Publicado: (2019)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
por: Gray, Steven G.
Publicado: (2021)

Immunohistochemistry for Claudin-4 and BAP1 in the Differential Diagnosis between Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma
por: Zuccatosta, Lina, et al.
Publicado: (2023)

Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG)
por: Geltner, Christian, et al.
Publicado: (2016)

Value of immunohistochemistry in the diagnosis of malignant cervical lymph nodes
por: de Natale Caly, Décio, et al.
Publicado: (2015)

Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application
por: Tomasetti, Marco, et al.
Publicado: (2010)

Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review
por: Töreyin, Zehra Nur, et al.
Publicado: (2020)

Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma
por: Martínez-Rivera, Vanessa, et al.
Publicado: (2018)

The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis
por: Volpi, Federica, et al.
Publicado: (2022)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Genomics and Epigenetics of Malignant Mesothelioma
por: Sage, Adam P., et al.
Publicado: (2018)

Applications of immunohistochemistry
por: Duraiyan, Jeyapradha, et al.
Publicado: (2012)

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma
por: Lennon, Frances E., et al.
Publicado: (2016)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
por: Lo Russo, Giuseppe, et al.
Publicado: (2018)

Basic immunohistochemistry for lymphoma diagnosis
por: Cho, Junhun
Publicado: (2022)

Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
por: Lagniau, Sabrina, et al.
Publicado: (2017)

The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
por: Banerji, Shantanu, et al.
Publicado: (2021)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Update on Immunohistochemistry for the Diagnosis of Lung Cancer
por: Inamura, Kentaro
Publicado: (2018)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l0he6edgn1bns52is18l2e977s